We earn commissions from brands listed on this site, which influences how listings are presented. Advertising Disclosure

7 min read

Sermorelin Storage and Handling: Refrigeration, Reconstitution, and Beyond-Use Dates

Did You Know

The instruction to refrigerate reconstituted sermorelin is not universal. The closest FDA-approved GHRH analog label says the opposite: do not freeze or refrigerate after mixing. Storage depends on your specific formulation, which is why the vial label beats any general rule you read online.

Sermorelin ships as a lyophilized powder that you reconstitute before first use, and how you handle it from that point affects whether the dose you inject is the dose you were prescribed. The most common question is whether it needs refrigeration. The honest answer is that it depends on your formulation, and the generic advice circulating online is not reliable.

Key Takeaways
  • Before reconstitution the powder is stable; after mixing, storage rules apply
  • The nearest FDA-approved GHRH analog label instructs not to freeze or refrigerate after mixing [1]
  • Many compounded sermorelin preparations do specify refrigeration. Follow your vial label
  • Swirl to dissolve. Do not shake [1]
  • Beyond-use dating is assigned by your compounding pharmacy under USP 797 [2]

Does Sermorelin Need Refrigeration?

This is where most published advice goes wrong by being too confident. Look at the closest approved comparator: the EGRIFTA WR label for tesamorelin instructs patients to store the vial at room temperature, 20 to 25 degrees C, in the original box to protect from light [1], and specifically not to freeze or refrigerate the product after it has been mixed with bacteriostatic water.

Compounded sermorelin is a different preparation from tesamorelin, and many compounding pharmacies do instruct patients to refrigerate the reconstituted vial. Both instructions can be correct for their own product, because formulation, preservative, and concentration all affect stability. What is not correct is applying one product's rule to another.

The rule that always applies

Follow the storage instruction and beyond-use date printed on your vial or dispensing label. If the label is unclear or missing, call the dispensing pharmacy rather than guessing from a general article. That includes this one.

Before and After Reconstitution

StageTypical handlingWhy
Unopened lyophilized vialPer pharmacy instruction, protected from lightFreeze-dried peptide is comparatively stable
During reconstitutionInject diluent slowly down the vial wallReduces mechanical stress on the peptide
Mixing[Swirl gently. Do not shake](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022505s020lbl.pdf) [1]Standard instruction on the approved analog label
After reconstitutionFollow the vial label, not a general ruleProducts differ; see above
Beyond-use dateAssigned by the pharmacy under [USP 797](https://www.usp.org/compounding/general-chapter-797) [2]Sterility, not just potency, drives the limit
In transit or travelKeep within the labeled range; do not freezeFreezing is discouraged across GHRH analog labeling [1]

Reconstituting Correctly

  1. Wash hands, swab both vial stoppers with alcohol, and let them dry
  2. Draw the exact volume of bacteriostatic water your pharmacy specified. Use only the diluent provided [1]
  3. Angle the needle so the water runs down the inside wall rather than jetting onto the powder
  4. Swirl in a slow circle until fully dissolved. Do not shake [1]
  5. Inspect the solution. It should be clear. Do not use it if it remains cloudy or shows particles
  6. Write the reconstitution date and the beyond-use date on the vial

The instruction not to shake appears on the approved analog label without an explanation attached. Follow it regardless of mechanism, since gentle handling costs nothing.

Beyond-Use Dating Is Not an Expiry Guess

Compounded sterile preparations carry a beyond-use date assigned under USP General Chapter 797 [2], which became official in November 2023. That date reflects sterility assurance as much as chemical potency, which is why it is often shorter than people expect and why extending it because the vial still looks fine is the wrong instinct.

If your protocol runs 6 months and each vial carries a beyond-use date well short of that, this is normal and is why sermorelin ships monthly rather than as a single large supply.

Traveling With Sermorelin

  • Keep medication in carry-on baggage, since cargo holds are not temperature controlled
  • Carry the pharmacy label and, if possible, a copy of the prescription
  • Use an insulated case with a cold pack if your product requires refrigeration, avoiding direct contact that could freeze it
  • Do not leave vials in a parked car, where temperatures exceed any labeled range quickly
  • For products shipped cold, note that some providers cannot reliably ship to Alaska or Hawaii at all

When to Discard a Vial

  • The beyond-use date has passed
  • The solution is cloudy, discolored, or contains visible particles
  • The vial was frozen, whether or not it has since thawed
  • The vial was left outside its labeled temperature range for an extended period
  • The stopper is damaged or the seal integrity is in question
If a dose was compromised

A single questionable vial is not a protocol failure, but record it in your log. If your 90-day IGF-1 comes back unchanged and you know a vial was mishandled, that is a plausible explanation to raise with your prescriber before assuming the dose was wrong.

Proper handling starts with a pharmacy-filled vial

Correct storage matters most when your sermorelin comes from a licensed compounding pharmacy in the first place. Embody is our top-ranked provider at $99/month with no insurance or bloodwork required, filled through a compounding pharmacy with handling instructions included.

See Embody

Frequently Asked Questions

Does sermorelin need to be refrigerated?

It depends on your specific formulation, and generic advice is unreliable here. The EGRIFTA WR label for tesamorelin, the closest FDA-approved GHRH analog, instructs storage at room temperature and specifically says not to freeze or refrigerate after mixing [1]. Many compounded sermorelin preparations do require refrigeration. Follow the storage instruction on your own vial or dispensing label, and call the pharmacy if it is unclear.

How long does reconstituted sermorelin last?

Your compounding pharmacy assigns a beyond-use date under USP General Chapter 797 [2], and that date is the operative limit. It accounts for sterility assurance as well as chemical stability, which is why it is frequently shorter than people expect. Do not extend it because the solution still looks clear.

Can I freeze sermorelin?

No. Freezing is discouraged across GHRH analog labeling; the EGRIFTA WR label instructs not to freeze the reconstituted product [1]. If a vial has been frozen, discard it rather than using it after thawing. When traveling with a refrigerated product, avoid placing vials in direct contact with cold packs, which can freeze them.

Why should I not shake the vial?

The approved GHRH analog label instructs users to move the vial in a circle to mix and explicitly not to shake it [1]. Swirl gently until the powder dissolves fully. The instruction is worth following as written; gentle handling has no downside.

What does bacteriostatic water do?

It is the diluent used to reconstitute the lyophilized powder, and it contains a preservative that inhibits bacterial growth, which is what allows a multi-dose vial to be used across several days. Use only the diluent your pharmacy provided [1] and the exact volume specified, since the volume determines your concentration and therefore how many syringe units your prescribed dose works out to.

How should I travel with sermorelin?

Keep it in carry-on baggage rather than checked luggage, since cargo holds are not temperature controlled. Bring the pharmacy label and ideally a copy of the prescription. If your product requires refrigeration, use an insulated case with a cold pack positioned so the vial cannot freeze against it. Never leave vials in a parked car.

References

  1. U.S. Food and Drug Administration EGRIFTA WR (tesamorelin) for injection, for subcutaneous use: full prescribing information FDA Drugs@FDA, 2025. NDA 022505/S-020. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022505s020lbl.pdf
  2. U.S. Pharmacopeia General Chapter <797> Pharmaceutical Compounding: Sterile Preparations USP, 2023. Official November 1, 2023. https://www.usp.org/compounding/general-chapter-797